A. Al-ahmad, F. Daschner, and K. Kümmerer, Biodegradability of cefotiam, ciprofloxacin, meropenem, penicillin G, and sulfamethoxazole and inhibition of waste water bacteria, Arch. Environ. Contam. Toxicol, vol.37, issue.2, pp.158-163, 1999.

A. Barrios-martinez, E. Barbot, B. Marrot, P. Moulin, and N. Roche, Degradation of phenol-containing effluents by MBR, J. Membrane Sci, vol.288, pp.288-296, 2006.

J. Besse, J. Latour, and J. Garric, Anticancer drugs in surface waters: what can we say about the occurrence and environmental significance of cytotoxic, cytostatic and endocrine therapy drugs?, Environ. Int, vol.39, issue.1, pp.73-86, 2012.

M. Bernhard, J. Müller, and T. Knepper, Biodegradation of persistent polar pollutants in wastewater: comparison of an optimised lab-scale membrane bioreactor and activated sludge treatment, Water Res, vol.40, pp.3419-3428, 2006.

K. Brown, J. Kulis, B. Thomson, T. Chapman, and D. Mawhinney, Occurrence of Antibiotics in Hospital, Residential, and Dairy Effluent, Municipal Wastewater, and the Rio, 2006.

, CASFM, Recommandations, 2013.

Y. Chen, G. Yu, Q. Cao, H. Zhang, Q. Lin et al., Occurrence and environmental implications of pharmaceuticals in Chinese municipal sewage sludge, Chemosphere, vol.93, issue.9, pp.1765-1772, 2013.

M. Clara, N. Kreuzinger, B. Strenn, O. Gans, and H. Kroiss, The solids retention time-a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants, Water Res, vol.39, pp.97-106, 2005.

L. Clouzot, Etude du bioréacteur à membrane pour l'élimination de l'hormone synthétique 17?-éthinylestradiol, 2009.

L. Clouzot, P. Doumenq, N. Roche, and B. Marrot, Kinetic parameters for 17a-ethinylestradiol removal by nitrifying activated sludge developed in a membrane bioreactor, Bioresour. Technol, vol.101, pp.6425-6431, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01024728

L. Clouzot, N. Roche, and B. Marrot, Effect of membrane bioreactor configurations on sludge structure and microbial activity, Bioresour. Technol, vol.102, issue.2, pp.975-981, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01292667

V. Cunningham, S. Binks, and M. Olson, Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment, Regul. Toxicol. Pharm, vol.53, pp.39-45, 2009.

H. D. Wever, S. Weiss, J. Vereecken, J. Müller, T. Knepper et al., Comparison of sulfonated and other micropollutants removal in membrane bioreactor and conventional wastewater treatment, Water Res, vol.41, pp.935-945, 2007.

L. Delgado, Bioréacteur à membrane externe pour le traitement d'effluents contenant des médicaments anticancéreux: élimination et influence du cyclophosphamide et de ses principaux métabolites sur le procédé, 2009.

N. Deloffre-bonnamour, Les rejets des établissements de santé: des effluents liquides aux déchets solides. Mémoire de maîtrise, 1995.

D. Dolar, M. Gros, S. Rodriguez-mozaz, J. Moreno, J. Comas et al., Removal of emerging contaminants from municipal wastewater with an integrated membrane system, MBR-RO, J. Hazard. Mater, pp.64-69, 2012.

E. , Évaluation des risques sanitaires et écotoxicologiques liés aux effluents hospitaliers, 2004.

E. Emmanuel, Y. Perrodin, G. Keck, J. M. Blanchard, and P. Vermande, Ecotoxicological risk assessment of hospital wastewater: a proposed framework for raw effluents discharging into urban sewer network, J. Hazard. Mater, vol.117, issue.1, pp.1-11, 2005.

A. Foster, Occurrence and Fate of Endocrine Disruptors Through the San Marcos Wastewater Treatment Plant, 2007.

M. Fram and K. Belitz, Occurrence and concentrations of pharmaceutical compounds in groundwater used for public drinking-water supply in California, Sci. Total Environ, vol.409, issue.18, pp.3409-3417, 2011.

J. Gagnaire, Couplage de procédés appliqué au traitement d'un effluent de compostage, 2010.

C. Gomez-canela, N. Cortes-francisco, C. Pujol, F. Ventura, S. Lacorte et al., Occurrence of cyclophosphamide and epirubicin in wastewaters by direct injection analysis-liquid chromatography-high-resolution mass spectrometry, Environ. Sci. Pollut. Res. Int, vol.19, issue.8, pp.3210-3218, 2012.

A. Grasmick, C. Cabassu, M. Spérandio, and C. Wisniewski, Bioréacteurs à membranes et traitement des eaux usées, Les techniques de l'ingénieur, p.4140, 2007.

E. Gullberg, S. Cao, O. G. Berg, C. Ilback, L. Sandergren et al., Selection of resistant bacteria at very low antibiotic concentrations, PLoS Pathog, 2011.

P. Hamon, P. Moulin, L. Ercolei, and B. Marrot, Performance of a biomass adapted to oncological ward wastewater vs. biomass from municipal WWTP on the removal of pharmaceutical molecules, Water Res, vol.128, pp.193-205, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02114290

S. Hann, A. E. Zs, A. K. Stefanka, A. G. Lenz, and . Stingeder, Novel separation method for highly sensitive speciation of cancerostatic platinum compounds by HPLC-ICP-MS, Anal. Bioanal. Chem, vol.381, pp.405-412, 2005.

P. Hartemann, A. Hautemaniere, and M. Joyeux, La problématique des effluents hospitaliers, Hygiène, vol.13, issue.5, pp.369-374, 2005.

L. Johnson, D. Lomax, M. Myers, O. Olson, S. Sol et al., Xenoestrogen exposure and effects in English sole (Parophrys vetulus) from, vol.88, pp.29-38, 2008.

A. Joss, E. Keller, A. Alder, A. Göbel, C. Mcardell et al., Removal of pharmaceuticals and fragrances in biological wastewater treatment, Water Res, vol.39, pp.3139-3152, 2005.

T. Junker, R. Alexy, T. Knacker, and K. Kümmerer, Biodegradability of 14C-Labeled antibiotics in a modified laboratory scale sewage treatment plant at environmentally relevant concentrations, Environ. Sci. Technol, vol.40, pp.318-324, 2006.

B. Kasprzyk-hordern, R. Dinsdale, and A. Guwy, The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters, Water Res, vol.43, pp.363-380, 2009.

K. Kimura, H. Hara, and Y. Watanabe, Removal of pharmaceutical compounds by submerged membrane bioreactors (MBRs), Desalination, vol.178, pp.135-140, 2005.

T. Kosjek and E. Heath, Occurrence, fate and determination of cytostatic pharmaceuticals in the environment, Trends Anal. Chem, vol.30, issue.7, pp.1065-1087, 2011.

L. Kovalova, H. Siegrist, H. Singer, A. Wittmer, and C. Mcardell, Hospital wastewater treatment by membrane bioreactor: performance and efficiency for organic micropollutant elimination, Environ. Sci. Technol, vol.46, pp.1536-1545, 2012.

B. Kraigher and I. Mandic-mulec, Nitrification activity and community structure of nitriteoxidizing bacteria in the bioreactors operated with addition of pharmaceuticals, J. Hazard. Mater, vol.188, pp.78-84, 2011.

K. Kümmerer, T. Steger-hartmann, and M. Meyer, Biodegradability of the anti-tumour agent ifosfamide and its occurrence in hospital effluents and communal sewage, Water Res, vol.31, issue.11, pp.2705-2710, 1997.

K. Kummerer and A. Al-ahmad, Biodegradability of the anti-tumor agents 5-fluorouracil, cytarabine, and gemcitabine: impact of the chemical structure and synergistic toxicity with hospital effluent, Acta Hydrochim. Hydrobiol, vol.25, issue.4, pp.166-172, 1997.

K. Kummerer and E. Helmers, Hospital effluents as a source of platinum for the environment, Sci. Total Environ, vol.193, pp.179-184, 1997.

K. Kümmerer, The presence of pharmaceuticals in the environment due to human use-present knowledge and future challenges, J. Environ. Manage, vol.90, issue.8, pp.2354-2366, 2009.

K. Li, A. Yediler, M. Yang, S. Schulte-hostede, and M. Wong, Ozonation of oxytetracycline and toxicological assessment of its oxidation by-products, Chemosphere, vol.72, pp.473-478, 2008.

S. Mahnik, K. Lenz, N. Weissenbacher, R. Mader, and M. Fuerhacker, Fate of 5-fluorouracil, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated sludge and treatment in a membrane-bio-reactor system, Chemosphere, vol.66, pp.30-37, 2007.

I. Michael, L. Rizzo, C. S. Mcardell, C. M. Manaia, C. Merlin et al., Urban wastewater treatment plants as hotspots for the release of antibiotics in the environment: a review, Water Res, vol.47, pp.957-995, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01507503

C. Miège, M. Favier, C. Brosse, J. P. Canler, and M. Coquery, Occurrence of betablockers in effluents of wastewater treatment plants from the Lyon area (France) and risk assessment for the downstream rivers, Talanta, vol.70, issue.4, pp.739-744, 2006.

J. Oh and J. Silverstein, Oxygen inhibition of activated sludge, Water Res, vol.33, issue.8, pp.1925-1937, 1999.

F. Orias and Y. Perrodin, Characterisaiton of the ecotoxicity of hospital effluents: a review, Sci. Total Environ, pp.250-276, 2013.

X. Peng, Z. Wang, W. Kuang, J. Tan, and K. Li, A preliminary study on the occurrence and behavior of sulfonamides, ofloxacin and chloramphenicol antimicrobials in wastewaters of two sewage treatment plants in Guangzhou, China, Sci. Total Environ, vol.371, issue.1-3, pp.314-322, 2006.

M. Petrovi?, B. ?krbi?, J. ?ivan?ev, L. Ferrando-climent, and D. Barcelo, Determination of 81 pharmaceutical drugs by high performance liquid chromatography coupled to mass spectrometry with hybrid triple quadrupole-linear ion trap in different types of water in Serbia, Sci. Total Environ, pp.415-428, 2014.

N. Prado, J. Ochoa, and A. Amrane, Biodegradation by activated sludge and toxicity of tetracycline into a semi-industrial membrane bioreactor, Bioresour. Technol, vol.100, pp.3769-3774, 2009.

J. Radjenovic, M. Petrovic, and D. Barcelo, Advanced mass spectrometric methods applied to the study of fate and removal of pharmaceuticals in wastewater treatment, Trends Anal. Chem, vol.26, issue.11, pp.1132-1144, 2007.

J. Radjenovic, M. Petrovic, and D. Barcelo, Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment, Water Res, vol.43, pp.831-841, 2009.

R. Rosal, A. Rodriguez, J. Perdigon-melon, A. Petre, E. Garcia-calvo et al., Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation, Water Res, vol.44, pp.578-588, 2010.

L. Santos, M. Gros, S. Rodriguez-mozaz, C. Delerue-matos, A. Pena et al., Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: identification of ecologically relevant pharmaceuticals, Sci. Total Environ, pp.302-316, 2013.

K. Seifert and F. Domka, Inhibiting effect of surfactants and heavy metal ions on the denitrification process, Pol. J. Environ. Stud, vol.14, issue.1, pp.87-93, 2004.

J. Seira, Rôle de la sorption et de la biodégradation dans l'élimination de micropolluants par des procédés d'épuration biologique: application aux molécules anticancéreuses traitées par bioréacteur à membrane, 2013.

J. Sipma, B. Osuna, N. Collado, H. Monclus, G. Ferrero et al., Comparison of removal of pharmaceuticals in MBR and activated sludge systems, Desalination, vol.250, issue.2, pp.653-659, 2010.

T. Stalder, Implication des effluents d'activités hospitalières et de la filière carnée sur la dissémination de l'antibiorésistance: dynamique des intégrons de l'émission au rejet, 2012.

K. Steger-hartmann, A. Kümmerer, and . Hartmann, Biological degradation of cyclophosphamide and its occurrence in sewage water, Ecotoxicol. Environ. Saf, vol.36, pp.174-179, 1997.

J. Straub, Combined environmental risk assessment for 5-fluorouracil and capecitabine in Europe, Integr. Environ. Assess. Manag, vol.6, pp.540-566, 2010.

J. Tambosi, R. Sena, M. Favier, W. Gebhardt, H. José et al., Removal of pharmaceutical compounds in membrane bioreactors (MBR) applying submerged membranes, Desalination, vol.261, pp.148-156, 2010.

T. Ternes, M. Bonerz, N. Herrmann, B. Teiser, and H. Andersen, Irrigation of treated wastewater in Braunschweig, Germany: an option to remove pharmaceuticals and musk fragrances, Chemosphere, vol.66, pp.894-904, 2007.

P. Verlicchi, A. Galetti, M. Petrovic, and D. Barcelo, Hospitals effluents as a source of emerging pollutants: an overview of micropollutants and sustainable treatment options, J. Hydrol, vol.389, issue.3-4, pp.416-428, 2010.

P. Verlicchi, M. Aukidy, A. Galletti, M. Petrovic, and D. Barcelo, Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment, Sci. Total Environ, vol.430, pp.109-118, 2012.

A. Watkinson, E. Murby, and S. Costanzo, Removal of antibiotics in conventional and advanced wastewater treatment: implications for environmental discharge and wastewater recycling, Water Res, vol.41, pp.4164-4176, 2007.

A. Watkinson, E. Murby, D. Kolpin, and S. Costanzo, The occurrence of antibiotics in an urban watershed: from wastewater to drinking water, Sci. Total Environ, vol.407, pp.2711-2723, 2009.

A. Wick, G. Fink, A. Joss, H. Siegrist, and T. Ternes, Fate of beta blockers and psychoactive drugs in conventional wastewater treatment, Water Res, vol.43, pp.1060-1074, 2009.

J. Yin, B. Shao, J. Zhang, and K. Li, A preliminary study on the occurrence of cytostatic drugs in hospital effluents in Beijing, China, Bull. Environ. Contam. Toxicol, vol.84, pp.39-45, 2010.

F. Zaviska, P. Drogui, A. Grasmick, A. Azais, and M. Héran, Nanofiltration membrane bioreactor for removing pharmaceutical compounds, J. Membr. Sci, vol.429, pp.121-129, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01689525

D. Zhang, R. Gesberg, W. Ng, and S. Tan, Removal of pharmaceuticas and personal care products in aquatic plant-based systems: a review, Environ. Pollut, vol.184, pp.620-639, 2014.

R. Zounkova, L. Kovalova, L. Blaha, and W. Dott, Ecotoxicity and genotoxicity of assessment of cytoyoxic antineoplastic drugs and their metabolites, Chemosphere, vol.81, pp.253-260, 2010.

E. Zuccato, S. Castiglioni, R. Bagnati, M. Melis, and R. Fanelli, Source, occurrence and fate of antibiotics in the Italian aquatic environment, J. Hazard. Mater, vol.179, issue.1-3, pp.1042-1048, 2010.